New testing in maternal hyperoxia — giving extra oxygen to pregnant people — shows that prenatal interventions might yield better outcomes for babies with congenital heart disease.
Scientists put AI to work analyzing study participants’ gaits, then had it develop personalized brain stimulation programs for each. UCSF researchers used AI to personalize Deep Brain Stimulation (DBS) for Parkinson's gait problems, leading to meaningful, customized improvements in walking and mobility—a major breakthrough for patients.
Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.
Martin Kampmann’s work, supported by the National Institutes of Science (NIH), maps cellular “decision points” that determine whether brain cells survive or die, laying the groundwork for treatments that intervene before irreversible brain damage occurs from dementia.
UCSF radiation oncologist David Raleigh, MD, PhD, studies the link between brain tumors and injectable birth control.
Chronic pain reroutes circuits in our nerves to the spinal cord and the brain. Understanding how this happens could help us reverse it. UCSF neurologist Dr. Shirvalkar studies nerve-to-brain connections to find new ways to treat chronic back pain.
Vikram Rao, director of the UCSF Epilepsy Center, discusses why a third of seizure patients don’t respond to medication and the promising new surgical and technological treatments available.
From curing Alzheimer’s to preventing cancer and pneumonia, UCSF postdoctoral scholars tackle complex medical conditions at annual Postdoc Slam competition. A TED Talk-style presentation on the effects of tangled DNA strands took first place at this year's Postdoc Slam competition, which is held in celebration of National Postdoc Appreciation Week.
UCSF pediatric neurologist Hannah Shapiro shares research on the latest treatment that could lead to less medication for kids. A UCSF headache specialist discusses how to identify and treat children's headaches, emphasizing prevention and new approaches like virtual therapy.
A study screened dyes found in textiles and in the laser industry that can be used in imaging for preclinical studies to diagnose and differentiate between neurodegenerative diseases. Currently, dyes used in mouse studies cannot distinguish between different types of dementia.